173 related articles for article (PubMed ID: 15482110)
1. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
Petersen E; Schmidt DR
Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
3. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
[TBL] [Abstract][Full Text] [Related]
5. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Chêne G; Thiébaut R
Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):299-304. PubMed ID: 19430657
[TBL] [Abstract][Full Text] [Related]
6. Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil.
de Melo Inagaki AD; Carvalheiro CG; Cipolotti R; Gurgel RQ; Rocha DA; Pinheiro KS; Araújo RM; Lima DR; Winandy JL; Mussi-Pinhata MM
Trop Med Int Health; 2012 Nov; 17(11):1349-55. PubMed ID: 22974376
[TBL] [Abstract][Full Text] [Related]
7. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Couvreur J
Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
[No Abstract] [Full Text] [Related]
8. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
Araujo FG; Lin T; Remington JS
J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
[TBL] [Abstract][Full Text] [Related]
10. Treatment of congenital toxoplasmosis.
Wilson CB
Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
[No Abstract] [Full Text] [Related]
11. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G
Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046
[TBL] [Abstract][Full Text] [Related]
12. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
13. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
14. Unresolved questions about the most successful known parasite.
Ajzenberg D
Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
[TBL] [Abstract][Full Text] [Related]
15. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
[TBL] [Abstract][Full Text] [Related]
16. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
17. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
[TBL] [Abstract][Full Text] [Related]
19. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
[TBL] [Abstract][Full Text] [Related]
20. Late cerebral relapse of congenital toxoplasmosis.
Robinson RO; Baumann RJ
Arch Dis Child; 1980 Mar; 55(3):231-2. PubMed ID: 7387168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]